See It All. Understand It All.
Get Started
SubscribeLogin
Memorial Day
Indy 500
Premier League
Motorsports
Social Media
Israel-Hamas Conflict
Soccer
Formula 1
Champions League
Drones
World Cup
South America
Published • loading... • Updated

The Servier laboratory refuses to sell Biogaran

Summary by Capital.fr
The French pharmaceutical laboratory Servier indicated on Friday that it was giving up the sale of its generic drug subsidiary Biogaran at this stage by “putting an end to discussions” with interested investors, thus confirming information published by L'Usine Nouvelle.

1 Articles

All
Left
Center
Right
1
Capital.frCapital.fr
Lean Right

The Servier laboratory refuses to sell Biogaran

The French pharmaceutical laboratory Servier indicated on Friday that it was giving up the sale of its generic drug subsidiary Biogaran at this stage by “putting an end to discussions” with interested investors, thus confirming information published by L'Usine Nouvelle.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Capital.fr broke the news in on Sunday, September 8, 2024.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

France

France

News
For You
SearchBlindspotLocal